• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Brain tumor survival: results from the National Cancer Data Base.

作者信息

Surawicz T S, Davis F, Freels S, Laws E R, Menck H R

机构信息

CBTRUS project, Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, 60612-7260, USA.

出版信息

J Neurooncol. 1998 Nov;40(2):151-60. doi: 10.1023/a:1006091608586.

DOI:10.1023/a:1006091608586
PMID:9892097
Abstract

Hospital-based data reported to the National Cancer Data Base (NCDB) were available for over 60,000 patients with a primary brain tumor diagnosed from 1985-1988 and 1990-1992. The most common histologies were glioblastomas, astrocytomas and meningiomas. Five-year survival rates for these tumors were 2%, 30% and 70% respectively. Histology, age at diagnosis, behavior, and location were important variables in estimating survival. Comparisons with population-based registry data suggest that the malignant tumors are well represented in NCDB, but the benign histologies are under-reported. Survival estimates for the malignant tumors are comparable to previously reported studies. The NCDB provides recent information on brain tumor distribution and survival patterns not available in other large databases.

摘要

相似文献

1
Brain tumor survival: results from the National Cancer Data Base.
J Neurooncol. 1998 Nov;40(2):151-60. doi: 10.1023/a:1006091608586.
2
The National Cancer Data Base report on patterns of childhood cancers in the United States.美国国家癌症数据库关于儿童癌症模式的报告。
Cancer. 1997 Dec 15;80(12):2321-32. doi: 10.1002/(sici)1097-0142(19971215)80:12<2321::aid-cncr14>3.0.co;2-w.
3
Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base.可用于描述原发性脑肿瘤发病率、生存率和治疗情况的集中式数据库:美国中央脑肿瘤登记处;监测、流行病学和最终结果;以及国家癌症数据库。
Neuro Oncol. 1999 Jul;1(3):205-11. doi: 10.1093/neuonc/1.3.205.
4
Primary Central Nervous System Tumors: Comparing Two National Cancer Registries.原发性中枢神经系统肿瘤:两个国家癌症登记处的比较。
World Neurosurg. 2019 Aug;128:e719-e731. doi: 10.1016/j.wneu.2019.04.247. Epub 2019 May 8.
5
Factors associated with survival in patients with meningioma.脑膜瘤患者生存相关因素。
J Neurosurg. 1998 May;88(5):831-9. doi: 10.3171/jns.1998.88.5.0831.
6
Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994.原发性脑和中枢神经系统肿瘤的描述性流行病学:来自美国中枢脑肿瘤登记处的结果,1990 - 1994年
Neuro Oncol. 1999 Jan;1(1):14-25. doi: 10.1093/neuonc/1.1.14.
7
Comparison of cases captured in the national cancer data base with those in population-based central cancer registries.比较国家癌症数据库中捕获的病例与基于人群的中央癌症登记处的病例。
Ann Surg Oncol. 2013 Jun;20(6):1759-65. doi: 10.1245/s10434-013-2901-1. Epub 2013 Mar 9.
8
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
9
Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.2010年美国原发性恶性脑肿瘤登记数据的完整患病率与其他常见癌症的比较。
Neuro Oncol. 2017 May 1;19(5):726-735. doi: 10.1093/neuonc/now252.
10
Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups.按行为和主要组织学分组对美国原发性脑肿瘤的患病率估计。
Neuro Oncol. 2001 Jul;3(3):152-8. doi: 10.1093/neuonc/3.3.152.

引用本文的文献

1
The Pivotal Role of Irradiation-induced Autophagy Mechanisms in Glioma Therapy.
Anticancer Agents Med Chem. 2025;25(18):1387-1404. doi: 10.2174/0118715206371143250402175030.
2
Tyr1497 in the BRG1 Bromodomain of the SWI/SNF Complex is Critical for the Binding and Function of a Selective BRG1 Inhibitor.SWI/SNF复合物的BRG1溴结构域中的Tyr1497对选择性BRG1抑制剂的结合和功能至关重要。
J Cell Mol Med. 2025 Mar;29(6):e70518. doi: 10.1111/jcmm.70518.
3
Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR.芦荟大黄素克服替莫唑胺的抗癌药物耐药性,并防止原发性人神经胶质瘤细胞系 NULU 和 ZAR 的集落形成和迁移。

本文引用的文献

1
The National Cancer Data Base and physician network.国家癌症数据库与医师网络。
Top Health Inf Manage. 1997 Feb;17(3):45-59.
2
Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.根据患者年龄和肿瘤组织学类型分层的原发性恶性脑肿瘤患者生存率:基于监测、流行病学和最终结果(SEER)数据的分析,1973 - 1991年
J Neurosurg. 1998 Jan;88(1):1-10. doi: 10.3171/jns.1998.88.1.0001.
3
The growth and maturation of the National Cancer Data Base.
Molecules. 2023 Aug 11;28(16):6024. doi: 10.3390/molecules28166024.
4
Next-generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma.新一代 SWI/SNF 复合物的溴结构域抑制剂增强胶质母细胞瘤中的 DNA 损伤和细胞死亡。
J Cell Mol Med. 2023 Sep;27(18):2770-2781. doi: 10.1111/jcmm.17907. Epub 2023 Aug 18.
5
The STAT3-Regulated Autophagy Pathway in Glioblastoma.胶质母细胞瘤中STAT3调控的自噬途径
Pharmaceuticals (Basel). 2023 Apr 29;16(5):671. doi: 10.3390/ph16050671.
6
Development and Validation of a Deep Learning Model for Brain Tumor Diagnosis and Classification Using Magnetic Resonance Imaging.利用磁共振成像开发和验证用于脑肿瘤诊断和分类的深度学习模型。
JAMA Netw Open. 2022 Aug 1;5(8):e2225608. doi: 10.1001/jamanetworkopen.2022.25608.
7
Socioeconomic Status Predicts Short-Term Emergency Department Utilization Following Supratentorial Meningioma Resection.社会经济地位可预测幕上脑膜瘤切除术后的短期急诊科利用率。
Cureus. 2022 Apr 26;14(4):e24508. doi: 10.7759/cureus.24508. eCollection 2022 Apr.
8
Biomedical Applications of Translational Optical Imaging: From Molecules to Humans.转化光学成像在生物医学中的应用:从分子到人。
Molecules. 2021 Nov 2;26(21):6651. doi: 10.3390/molecules26216651.
9
Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients.染色质可及性分析鉴定 GSTM1 为人类胶质母细胞瘤患者的预后标志物。
Clin Epigenetics. 2021 Nov 3;13(1):201. doi: 10.1186/s13148-021-01181-8.
10
Cytotoxicity Effect of Quinoin, Type 1 Ribosome-Inactivating Protein from Quinoa Seeds, on Glioblastoma Cells.藜麦种子 1 型核糖体失活蛋白 Quinoin 对神经胶质瘤细胞的细胞毒性作用。
Toxins (Basel). 2021 Sep 25;13(10):684. doi: 10.3390/toxins13100684.
国家癌症数据库的发展与成熟
Cancer. 1997 Dec 15;80(12):2296-304. doi: 10.1002/(sici)1097-0142(19971215)80:12<2296::aid-cncr11>3.0.co;2-p.
4
Incidence and survival of intracranial meningioma patients in Norway 1963-1992.1963年至1992年挪威颅内脑膜瘤患者的发病率和生存率
Neuroepidemiology. 1997;16(2):53-9. doi: 10.1159/000109671.
5
The National Cancer Data Base report on patterns of hospital reporting.国家癌症数据库关于医院报告模式的报告。
Cancer. 1996 Oct 15;78(8):1829-37. doi: 10.1002/(sici)1097-0142(19961015)78:8<1829::aid-cncr26>3.0.co;2-z.
6
Audit in the management of gliomas.胶质瘤管理中的审计
Br J Neurosurg. 1993;7(1):61-9. doi: 10.3109/02688699308995057.
7
Long-term survival in malignant glioma. Prognostic factors.恶性胶质瘤的长期生存。预后因素。
J Fla Med Assoc. 1993 Mar;80(3):181-4.
8
Primary tumors of the brain, cranial nerves and cranial meninges in Victoria, Australia, 1982-1990: patterns of incidence and survival.1982 - 1990年澳大利亚维多利亚州脑、颅神经和颅脑膜原发性肿瘤:发病率及生存模式
Neuroepidemiology. 1993;12(5):270-9. doi: 10.1159/000110328.
9
On the estimation of survival.
Semin Surg Oncol. 1994 Jan-Feb;10(1):2-6. doi: 10.1002/ssu.2980100103.
10
Brain, other central nervous system, and eye cancer.脑癌、其他中枢神经系统癌症和眼癌。
Cancer. 1995 Jan 1;75(1 Suppl):330-7. doi: 10.1002/1097-0142(19950101)75:1+<330::aid-cncr2820751315>3.0.co;2-5.